Intellia Therapeutics Inc...

NASDAQ: NTLA · Real-Time Price · USD
10.90
-0.10 (-0.91%)
At close: Aug 14, 2025, 3:59 PM
11.04
1.28%
Pre-market: Aug 15, 2025, 09:11 AM EDT

Intellia Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-519.02M -481.19M -474.19M -267.89M
Depreciation & Amortization
10.29M 8.98M 7.57M 6.89M
Stock-Based Compensation
154.27M 134.05M 91.4M 47.01M
Other Working Capital
-22.86M -22.29M -47.55M -31.36M
Other Non-Cash Items
-6.29M -3.47M 95.8M 2.94M
Deferred Income Tax
n/a n/a n/a 8.93M
Change in Working Capital
11.88M -52.45M -53.87M -22.9M
Operating Cash Flow
-348.88M -394.09M -333.29M -225.03M
Capital Expenditures
-5.78M -13.98M -58.39M -12.76M
Cash Acquisitions
n/a n/a -44.68M -3M
Purchase of Investments
-935.57M -904.46M -429.03M -1.02B
Sales Maturities Of Investments
1.07B 887.1M 647.58M 485.6M
Other Investing Acitivies
n/a n/a 44.83M n/a
Investing Cash Flow
125.57M -31.35M 160.31M -550.78M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
8.85M 10.53M 17.17M 43.12M
Financial Cash Flow
185.75M 130.32M 582.96M 736.69M
Net Cash Flow
-37.57M -295.11M 409.98M -39.12M
Free Cash Flow
-354.66M -408.07M -391.68M -237.79M